Armata Pharmaceuticals (ARMP) EPS (Basic) (2016 - 2018)
Historic EPS (Basic) for Armata Pharmaceuticals (ARMP) over the last 6 years, with Q4 2018 value amounting to -$0.24.
- Armata Pharmaceuticals' EPS (Basic) fell 50000.0% to -$0.24 in Q4 2018 from the same period last year, while for Dec 2018 it was -$1.56, marking a year-over-year increase of 5243.9%. This contributed to the annual value of -$0.52 for FY2024, which is 7277.49% up from last year.
- As of Q4 2018, Armata Pharmaceuticals' EPS (Basic) stood at -$0.24, which was down 50000.0% from -$0.6 recorded in Q3 2018.
- In the past 5 years, Armata Pharmaceuticals' EPS (Basic) ranged from a high of $3.87 in Q3 2014 and a low of -$9.66 during Q4 2016
- Over the past 5 years, Armata Pharmaceuticals' median EPS (Basic) value was -$0.6 (recorded in 2018), while the average stood at -$1.75.
- The largest annual percentage gain for Armata Pharmaceuticals' EPS (Basic) in the last 5 years was 170000.0% (2014), contrasted with its biggest fall of 1182457.44% (2014).
- Quarter analysis of 5 years shows Armata Pharmaceuticals' EPS (Basic) stood at -$0.27 in 2014, then crashed by 121.51% to -$0.59 in 2015, then tumbled by 1543.1% to -$9.66 in 2016, then soared by 99.59% to -$0.04 in 2017, then crashed by 500.0% to -$0.24 in 2018.
- Its last three reported values are -$0.24 in Q4 2018, -$0.6 for Q3 2018, and -$0.68 during Q2 2018.